The long-term goal of this research is to devise a novel and practical tRNA aminoacylation system based on ribozymes, which facilitates the technique of nonnatural amino acid mutagenesis and thus raises it to a more user-accessible technology. An artificial ribozyme selected in our laboratory exhibits a broad spectrum of activities toward phenylalanine (Phe) analogs and suppressor tRNAs bearing different nonsense codons. By immobilizing this ribozyme (called PheFlexizyme) on a resin, the synthesis of suppressor tRNAs charged with Phe analogs is largely facilitated; where a user-specified tRNA and a Phe analog are reacted on this resin and the resulting filtrate (or supernatant) contains the desired aminoacyl-tRNA. This charged tRNA is then used in a cell-free translation system to incorporate a Phe analog at a single position or two Phe analogs at two specific positions. The entire processes, including tRNA charging, in vitro translation, and purification of protein, can be done in one day. The translation efficiency is generally 50-70 mu/g/mL, thus it is feasible to produce a sufficient amount of protein for further biological studies. It should be noted that the PheFlexizyme-resin can be reused more than 10 times, and therefore it is also economical. In this application, we will attempt to develop more sophisticated ribozyme aminoacylation technologies.
Specific aims are (1) expanding repertoire of Phe analogs for PheFlexizyme, (2) in vitro evolution of new Flexizymes based on the PheFIlexizyme scaffold, (3) in situ generation of PheFlexizyme in the cell-free transcription-coupled translation apparatus, and (4) applications of PheFlexizyme.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059159-07
Application #
7012204
Study Section
Biochemistry Study Section (BIO)
Program Officer
Jones, Warren
Project Start
2000-02-01
Project End
2008-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
7
Fiscal Year
2006
Total Cost
$320,760
Indirect Cost
Name
State University of New York at Buffalo
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Ohta, Atsushi; Yamagishi, Yusuke; Suga, Hiroaki (2008) Synthesis of biopolymers using genetic code reprogramming. Curr Opin Chem Biol 12:159-67
Kang, Taek Jin; Suga, Hiroaki (2008) Ribosomal synthesis of nonstandard peptides. Biochem Cell Biol 86:92-9
Ohta, Atsushi; Murakami, Hiroshi; Higashimura, Eri et al. (2007) Synthesis of polyester by means of genetic code reprogramming. Chem Biol 14:1315-22
Ohuchi, Masaki; Murakami, Hiroshi; Suga, Hiroaki (2007) The flexizyme system: a highly flexible tRNA aminoacylation tool for the translation apparatus. Curr Opin Chem Biol 11:537-42
Kang, Taek Jin; Suga, Hiroaki (2007) In vitro selection of a 5'-purine ribonucleotide transferase ribozyme. Nucleic Acids Res 35:4186-94
Murakami, Hiroshi; Ohta, Atsushi; Ashigai, Hiroshi et al. (2006) A highly flexible tRNA acylation method for non-natural polypeptide synthesis. Nat Methods 3:357-9
Hodgson, David R W; Suga, Hiroaki (2004) Mechanistic studies on acyl-transferase ribozymes and beyond. Biopolymers 73:130-50
Murakami, Hiroshi; Saito, Hirohide; Suga, Hiroaki (2003) A versatile tRNA aminoacylation catalyst based on RNA. Chem Biol 10:655-62
Murakami, Hiroshi; Bonzagni, Neil J; Suga, Hiroaki (2002) Aminoacyl-tRNA synthesis by a resin-immobilized ribozyme. J Am Chem Soc 124:6834-5
Ming, Xiaotian; Smith, Kristina; Suga, Hiroaki et al. (2002) Recognition of tRNA backbone for aminoacylation with cysteine: evolution from Escherichia coli to human. J Mol Biol 318:1207-20

Showing the most recent 10 out of 14 publications